Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Greinacher

Showing results (61-70 of 166) with videos related to

Pageof 17
Sort By:
Vox Sanguinis|September 22, 2009
Factors influencing confidential unit exclusions in blood donorsA Sümnig, U Konerding, T Kohlmann, et al.
The Biochemical Journal|September 1, 1995
Platelet phospholipase D is activated by protein kinase C via an integrin alpha IIb beta 3-independent mechanismE A Martinson, S Scheible, A Greinacher, et al.
Blood|January 15, 1998
Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patientsJ Polgár, P Eichler, A Greinacher, et al.
European Journal of Haematology|March 13, 2003
Role of variant Creutzfeldt-Jakob disease for safety of treatment with blood components: screening of lymphatic tissue is a potential tool for risk assessmentC Sachse, M H Groschup, R Warzok, et al.
European Journal of Pediatrics|January 29, 2000
Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodiumO Ranze, P Ranze, H N Magnani, et al.
Thrombosis Research|July 15, 1993
Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172)A Greinacher, T Eckhardt, J Mussmann, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|February 1, 1993
[Septic-toxic heart failure as a result of a heparin-induced thrombocytopenia with "white-clot-syndrome"]S Kleinschmidt, T Ziegenfuss, U T Seyfert, et al.
Intensive Care Medicine|May 1, 1997
Severe arterial and venous thrombosis in a patient with heparin-induced thrombocytopenia type IIU Janssens, H G Klues, A Greinacher, et al.
Vox Sanguinis|July 20, 2016
Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysisT Thiele, T Alt-Mayer, A Greinacher, et al.
Der Unfallchirurg|January 1, 1995
[Heparin-associated thrombocytopenia caused by low-molecular-weight heparin]J Köninger, A Greinacher, W Müller-Beissenhirtz, et al.
Pageof 17

Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
Vox Sanguinis|September 22, 2009
Factors influencing confidential unit exclusions in blood donorsA Sümnig, U Konerding, T Kohlmann, et al.
The Biochemical Journal|September 1, 1995
Platelet phospholipase D is activated by protein kinase C via an integrin alpha IIb beta 3-independent mechanismE A Martinson, S Scheible, A Greinacher, et al.
Blood|January 15, 1998
Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patientsJ Polgár, P Eichler, A Greinacher, et al.
European Journal of Haematology|March 13, 2003
Role of variant Creutzfeldt-Jakob disease for safety of treatment with blood components: screening of lymphatic tissue is a potential tool for risk assessmentC Sachse, M H Groschup, R Warzok, et al.
European Journal of Pediatrics|January 29, 2000
Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodiumO Ranze, P Ranze, H N Magnani, et al.
Thrombosis Research|July 15, 1993
Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172)A Greinacher, T Eckhardt, J Mussmann, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|February 1, 1993
[Septic-toxic heart failure as a result of a heparin-induced thrombocytopenia with "white-clot-syndrome"]S Kleinschmidt, T Ziegenfuss, U T Seyfert, et al.
Intensive Care Medicine|May 1, 1997
Severe arterial and venous thrombosis in a patient with heparin-induced thrombocytopenia type IIU Janssens, H G Klues, A Greinacher, et al.
Vox Sanguinis|July 20, 2016
Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysisT Thiele, T Alt-Mayer, A Greinacher, et al.
Der Unfallchirurg|January 1, 1995
[Heparin-associated thrombocytopenia caused by low-molecular-weight heparin]J Köninger, A Greinacher, W Müller-Beissenhirtz, et al.
Pageof 17